🔗 Permalink

Inventor profile of:

Clark Pan

City:

Castro Valley, California

Country:

United States

Published Applications:

Last publication date:

2011-07-28

Top Assignees for applications by Clark Pan

The entities that hold a legal rights for patent applications filed by inventor Pan Clark:

Bayer Pharmaceuticals Corporation 12 West Haven, CT United States
AEROVANCE, INC. 2 Berkeley, CA United States
BAYER HEALTHCARE LLC 2 Tarrytown, NY United States
Bayer Corporation 1 Berkely, CA United States
BAYER CORPORATION 1 Pittsburgh, PA United States
Bayer Pharmaceuticals Corp 1 West Haven, CT United States
Bayer Aktiengesellschaft 1 Leverkusen, Germany
BAYER HEALTHCARE AG 1 Leverkusen, Germany

Recent patent applications by Pan Clark

Clark Pan from Castro Valley, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2011-07-28

US20110183920A1

Chemistry; metallurgy

MODIFIED IL-4 MUTEIN RECEPTOR ANTAGONISTS

#2 | 2009-10-15

US20090258826A1

Chemistry; metallurgy

Pituitary adenylate cyclase activating peptide (PACAP) receptor (VPAC2) agonists and their pharmacological methods of use

#3 | 2008-10-23

US20080261863A1

Chemistry; metallurgy

Pegylation of Vasoactive Intestinal Peptide (Vip) / Pituitary Adenylate Cyclase Activating Peptide (Pacap) Receptor 2 (Vpac2) Agonists and Methods of Use

#4 | 2008-05-27

US10618126

Pituitary adenylate cyclase activating peptide (PACAP) receptor (VPAC2) agonist peptide

#5 | 2007-07-12

US20070160614A1

Chemistry; metallurgy

Human TIMP-1 antibodies

#6 | 2006-08-15

US10128520

Human TIMP-1 antibodies

#7 | 2006-05-09

US10345751

Methods of treating type 2 diabetes with peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists

#8 | 2006-01-05

US20060003935A1

Chemistry; metallurgy

Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use

#9 | 2006-01-05

US20060003934A1

Chemistry; metallurgy

Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use

#10 | 2006-01-05

US20060003419A1

Chemistry; metallurgy

Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use

#11 | 2006-01-05

US20060003418A1

Chemistry; metallurgy

Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use

#12 | 2006-01-05

US20060003417A1

Chemistry; metallurgy

Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use

#13 | 2005-12-29

US20050288248A1

Chemistry; metallurgy

Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use

#14 | 2005-12-06

US9671773

Pituitary adenylate cyclase activating peptide (PACAP)receptor 3 (R3) agonists and their pharmacological methods of use

#15 | 2005-09-15

US20050203009A1

Chemistry; metallurgy

VPAC1 selective antagonists and their pharmacological methods of use

#16 | 2005-07-14

US20050153890A1

Chemistry; metallurgy

Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use

#17 | 2005-03-17

US20050059590A1

Human necessities

Modified IL-4 mutein receptor antagonists

#18 | 2005-03-08

US10265345

Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use

#19 | 2005-02-24

US20050043237A1

Chemistry; metallurgy

Pituitary adenylate cyclase activating peptide (PACAP) receptor 3 (R3) agonists and their pharmacological methods of use

InventorID:

3555991 ⎘